Bruker (BRKRP) Income from Non-Controlling Interests (2010 - 2026)
Bruker (BRKRP) reported Income from Non-Controlling Interests of $1.3 million for Q1 2026, up 316.67% on a YoY basis from $312000.0 in Q1 2025, and down 59.38% quarter-over-quarter from $3.2 million in Q4 2025.
Bruker (BRKRP) Income from Non-Controlling Interests (2010 - 2026) Analysis & Trends
Bruker has reported Income from Non-Controlling Interests for 17 years, with the latest figure at $1.3 million in Q1 2026.
- For the quarter ending Q1 2026, Income from Non-Controlling Interests rose 316.67% year-over-year to $1.3 million; the trailing twelve-month figure through Mar 2026 stood at $2.2 million (up 320.0% YoY), and the FY2025 full-year result was $300000.0, down 57.14% from the prior year.
- Income from Non-Controlling Interests for Q1 2026 stood at $1.3 million, down from $3.2 million in the prior quarter.
- The five-year high for Income from Non-Controlling Interests was $3.2 million in Q4 2025, with the low at -$3.4 million in Q2 2025.
- Historically, Income from Non-Controlling Interests has averaged $343750.0 across 5 years, with a median of $550000.0 in 2022.
- Annual changes were most pronounced in 2023 — Income from Non-Controlling Interests sank 200.0% — and 2025, when it jumped 1500.0%.
- Bruker's Income from Non-Controlling Interests stood at $900000.0 in 2022, then slumped by 200.0% to -$900000.0 in 2023, then soared by 122.22% to $200000.0 in 2024, then jumped by 1500.0% to $3.2 million in 2025, then plunged by 59.38% to $1.3 million in 2026.
- The last three Income from Non-Controlling Interests figures came in at $1.3 million (Q1 2026), $3.2 million (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | - |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | - |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 6.00 Mn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 22.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -5.85 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | - |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 100,000.00 |
| 10 | Bruker | - | - | 379.80 Mn | 1.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.30 Mn |
| Dec 31, 2025 | 3.20 Mn |
| Sep 30, 2025 | 1.10 Mn |
| Jun 30, 2025 | -3.40 Mn |
| Mar 31, 2025 | -600,000.00 |
| Dec 31, 2024 | 200,000.00 |
| Sep 30, 2024 | -600,000.00 |
| Mar 31, 2024 | 1.10 Mn |
| Dec 31, 2023 | -900,000.00 |
| Sep 30, 2023 | 600,000.00 |
| Jun 30, 2023 | 700,000.00 |
| Mar 31, 2023 | 900,000.00 |
| Dec 31, 2022 | 900,000.00 |
| Sep 30, 2022 | 300,000.00 |
| Jun 30, 2022 | 200,000.00 |
| Mar 31, 2022 | 500,000.00 |
| Dec 31, 2021 | 300,000.00 |
| Sep 30, 2021 | 1.00 Mn |
| Jun 30, 2021 | 1.10 Mn |
| Mar 31, 2021 | 1.10 Mn |